Article
SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans.
The Journal of clinical investigation - 1 Mar 2011
Liu Kun-Wei, Feng Haizhong, Bachoo Robert, Kazlauskas Andrius, Smith Erin M, Symes Karen, Hamilton Ronald L, Nagane Motoo, Nishikawa Ryo, Hu Bo, Cheng Shi-Yuan
Abstract excerpt
Recent collaborative efforts have subclassified malignant glioblastomas into 4 clinical relevant subtypes based on their signature genetic lesions. Platelet-derived growth factor receptor α (PDGFRA) overexpression is concomitant with a loss of cyclin-dependent kinase inhibitor 2A (CDKN2A) locus (encoding P16INK4A and P14ARF) in a large number of tumors within one subtype of glioblastomas. Here we report that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
